SE417196B - PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES - Google Patents

PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES

Info

Publication number
SE417196B
SE417196B SE7701795A SE7701795A SE417196B SE 417196 B SE417196 B SE 417196B SE 7701795 A SE7701795 A SE 7701795A SE 7701795 A SE7701795 A SE 7701795A SE 417196 B SE417196 B SE 417196B
Authority
SE
Sweden
Prior art keywords
metylamines
propandiols
dioxan
intermediates
preparation
Prior art date
Application number
SE7701795A
Other languages
Swedish (sv)
Other versions
SE7701795L (en
Inventor
R N Booher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE7701795L publication Critical patent/SE7701795L/en
Publication of SE417196B publication Critical patent/SE417196B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
SE7701795A 1972-12-08 1977-02-17 PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES SE417196B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31322172A 1972-12-08 1972-12-08

Publications (2)

Publication Number Publication Date
SE7701795L SE7701795L (en) 1977-02-17
SE417196B true SE417196B (en) 1981-03-02

Family

ID=23214841

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (en) 1972-12-08 1973-12-07 PROCEDURE FOR DISPOSAL OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT
SE7701796A SE428378B (en) 1972-12-08 1977-02-17 ANALOGY PROCEDURE FOR PREPARING DROXAND DERIVATIVES
SE7701795A SE417196B (en) 1972-12-08 1977-02-17 PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7316586A SE403377B (en) 1972-12-08 1973-12-07 PROCEDURE FOR DISPOSAL OF DIOXAN DERIVATIVES WITH THERAPEUTIC, SPECIAL ANALGETIC EFFECT
SE7701796A SE428378B (en) 1972-12-08 1977-02-17 ANALOGY PROCEDURE FOR PREPARING DROXAND DERIVATIVES

Country Status (27)

Country Link
JP (2) JPS5734835B2 (en)
AR (3) AR206306A1 (en)
AT (2) AT330773B (en)
BE (1) BE808340A (en)
BG (4) BG21409A3 (en)
CA (2) CA1014560A (en)
CH (4) CH605903A5 (en)
CS (3) CS193480B2 (en)
CY (1) CY1017A (en)
DD (3) DD109625A5 (en)
DE (1) DE2361340C2 (en)
DK (1) DK134717B (en)
ES (4) ES421291A1 (en)
FR (1) FR2209578B1 (en)
GB (2) GB1455997A (en)
HK (1) HK60479A (en)
HU (2) HU168620B (en)
IE (1) IE40226B1 (en)
IL (1) IL43773A (en)
KE (1) KE2976A (en)
MY (1) MY8000064A (en)
NL (1) NL7316839A (en)
PH (2) PH15197A (en)
SE (3) SE403377B (en)
SU (4) SU587861A3 (en)
YU (3) YU36171B (en)
ZA (1) ZA739207B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6030752B2 (en) * 2012-05-09 2016-11-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Method for producing oxetane-3-ylmethanamine
LV14983B (en) * 2013-10-15 2015-06-20 Olainfarm, A/S Method for producing intermediates of phenibut

Also Published As

Publication number Publication date
NL7316839A (en) 1974-06-11
YU318473A (en) 1980-09-25
GB1455997A (en) 1976-11-17
ES444911A1 (en) 1977-09-01
IE40226B1 (en) 1979-04-11
DD115653A5 (en) 1975-10-12
BE808340A (en) 1974-06-07
AR212012A1 (en) 1978-04-28
DK134717C (en) 1977-05-31
JPS4987680A (en) 1974-08-22
ATA1026073A (en) 1975-10-15
AR212416A1 (en) 1978-07-14
MY8000064A (en) 1980-12-31
AT332396B (en) 1976-09-27
ZA739207B (en) 1975-07-30
AU6321773A (en) 1975-06-05
SE7701796L (en) 1977-02-17
HU168763B (en) 1976-07-28
SE403377B (en) 1978-08-14
BG26205A4 (en) 1979-02-15
AT330773B (en) 1976-07-26
DE2361340A1 (en) 1974-06-12
CA1024150A (en) 1978-01-10
YU36171B (en) 1982-02-25
DD110864A5 (en) 1975-01-12
GB1455998A (en) 1976-11-17
JPS4987681A (en) 1974-08-22
SE428378B (en) 1983-06-27
BG22386A3 (en) 1977-02-20
AR206306A1 (en) 1976-07-15
YU109380A (en) 1981-04-30
CS222209B2 (en) 1983-05-27
DE2361340C2 (en) 1983-11-24
BG21223A3 (en) 1976-03-20
ATA1026173A (en) 1976-01-15
IL43773A0 (en) 1974-03-14
YU36020B (en) 1981-11-13
CH619219A5 (en) 1980-09-15
SU578001A3 (en) 1977-10-25
SU587861A3 (en) 1978-01-05
CH605903A5 (en) 1978-10-13
JPS5742633B2 (en) 1982-09-09
HU168620B (en) 1976-06-28
CH614439A5 (en) 1979-11-30
ES444716A1 (en) 1977-05-16
DK134717B (en) 1977-01-03
YU318573A (en) 1981-06-30
JPS5734835B2 (en) 1982-07-26
BG21409A3 (en) 1976-05-20
HK60479A (en) 1979-08-31
SE7701795L (en) 1977-02-17
PH14923A (en) 1982-01-29
PH15197A (en) 1982-09-17
SU648081A3 (en) 1979-02-15
KE2976A (en) 1979-07-20
CS193480B2 (en) 1979-10-31
CA1014560A (en) 1977-07-26
YU35447B (en) 1981-02-28
DD109625A5 (en) 1974-11-12
ES421291A1 (en) 1976-07-01
FR2209578B1 (en) 1977-09-02
CY1017A (en) 1979-11-23
CH630914A5 (en) 1982-07-15
CS222208B2 (en) 1983-05-27
FR2209578A1 (en) 1974-07-05
ES421290A1 (en) 1976-07-01
SU663305A3 (en) 1979-05-15
IL43773A (en) 1979-05-31
IE40226L (en) 1974-06-08

Similar Documents

Publication Publication Date Title
SE400280B (en) 2-HALOGEN-4-SUBSTITUTED-6,7,8-TRIALCOXIKINAZOLINES FOR USE AS AN INTERMEDIATE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE 2-SUBSTITUTED-4-AMINO-6,7,8-TRIALKOXIKINAZ
SE407579B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLICIN
NO139560C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE NONAPEPTIDAMIDE DERIVATIVES
SE397257B (en) PROCEDURE FOR THE PREPARATION OF SUGAROSIZED DETERGENTS
SE7710602L (en) INTERMEDIATES FOR THE PREPARATION OF BENZOXAZOLE DERIVATIVES
IT975971B (en) PROCEDURE FOR THE PREPARATION OF CHLOROSILANS
NO140731C (en) PROCEDURE FOR THE PREPARATION OF DIMETHYLETER
SE386892B (en) PROCEDURE FOR THE PREPARATION OF OXAMINO COMPOUNDS
SE382053B (en) PROCEDURE FOR THE PREPARATION OF BIFENYLYL ALKANOYLAMINOPYRIDINES
SE389856B (en) PROCEDURE FOR THE PREPARATION OF ALKALIPER CARBONATES
SE383151B (en) PROCEDURE FOR THE PREPARATION OF 1-HYDROXY-2-PYRIDONES
SE380272B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONE METHYLLYCINE
SE393111B (en) PROCEDURE FOR THE PREPARATION OF D-2-HALOGEN-6-METHYL-8-SUBSTITUTED - ERGOLINE
FI56830B (en) PROCEDURE FOR THE PREPARATION OF ASPARAGINYLGRUPPER INNEHAOLLANDE BIOLOGISKT AKTIVA POLYPEPTIDER
SE393808B (en) PROCEDURE FOR THE PREPARATION OF ISOMALTITE
SE415355B (en) PROCEDURE FOR THE PREPARATION OF PHOSPHONOTIOUREIDS
NO142624C (en) COMPOUNDS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 4-AMINOAMPHETAMINE DERIVATIVES
AR197040A1 (en) PROCEDURE FOR THE PREPARATION OF NEW BIPHENYLACETAMIDES
IT956743B (en) PROCEDURE FOR THE PREPARATION OF ALKYLSULPHONATED COMPOUNDS
SE391717B (en) PROCEDURE FOR THE PREPARATION OF 4-ARYL-5-AMINOALKYL-4-OXAZOLIN-2-ONERS
SE417196B (en) PROPANDIOLS FOR USE AS INTERMEDIATES FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE M-DIOXAN-5-METYLAMINES
IT996099B (en) PROCEDURE FOR THE PREPARATION OF AMINOANTHRACHINONE
DK555680A (en) BENZOCYCLOPTATHIOPHENDER DERIVATIVES USED AS INTERMEDIATES IN THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZOCYCLOPTATHIOPHENDER DERIVATIVES
SE389862B (en) PROCEDURE FOR THE PREPARATION OF ALFA-6-DEOXITETTRACYCLINES
IT977792B (en) PROCEDURE FOR THE PREPARATION OF CYANIDRINS